Checkpoint Inhibitors Global Market Report 2025

Published Apr 09, 2025

Length 250 Pages

SKU # BRC19913373

Description

Checkpoint Inhibitors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on checkpoint inhibitors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for checkpoint inhibitors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The checkpoint inhibitors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug: PD-1 Inhibitors; PD-L1 Inhibitors; CTLA-4; Chimeric Antigen Receptor T-cell; Other Drugs

2) By Application: Lung Cancer; Renal Cancer; Blood Cancer; Bladder Cancer; Melanoma; Other Applications

3) By End-Users: Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:

1) By PD-1 Inhibitors: Pembrolizumab (Keytruda); Nivolumab (Opdivo)

2) By PD-L1 Inhibitors: Atezolizumab (Tecentriq); Durvalumab (Imfinzi); Avelumab (Bavencio)

3) By CTLA-4: Ipilimumab (Yervoy)

4) By Chimeric Antigen Receptor T-cell: CAR T-cell Therapy Products

5) By Other Drugs: Combination Therapies; Emerging Checkpoint Inhibitors

Companies Mentioned: AstraZeneca plc; Bristol-Myers Squibb Company; Merck & Co. Inc.; Roche Holding AG; Pfizer Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Checkpoint Inhibitors Market Characteristics
3. Checkpoint Inhibitors Market Trends And Strategies
4. Checkpoint Inhibitors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Checkpoint Inhibitors Growth Analysis And Strategic Analysis Framework: 5.1. Global Checkpoint Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Checkpoint Inhibitors Market Growth Rate Analysis; 5.4. Global Checkpoint Inhibitors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Checkpoint Inhibitors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Checkpoint Inhibitors Total Addressable Market (TAM)
6. Checkpoint Inhibitors Market Segmentation: 6.1. Global Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; PD-1 Inhibitors; PD-L1 Inhibitors; CTLA-4; Chimeric Antigen Receptor T-cell; Other Drugs; 6.2. Global Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Lung Cancer; Renal Cancer; Blood Cancer; Bladder Cancer; Melanoma; Other Applications; 6.3. Global Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies; 6.4. Global Checkpoint Inhibitors Market, Sub-Segmentation Of PD-1 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Pembrolizumab (Keytruda); Nivolumab (Opdivo); 6.5. Global Checkpoint Inhibitors Market, Sub-Segmentation Of PD-L1 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Atezolizumab (Tecentriq); Durvalumab (Imfinzi); Avelumab (Bavencio); 6.6. Global Checkpoint Inhibitors Market, Sub-Segmentation Of CTLA-4, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Ipilimumab (Yervoy); 6.7. Global Checkpoint Inhibitors Market, Sub-Segmentation Of Chimeric Antigen Receptor T-cell, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; CAR T-cell Therapy Products; 6.8. Global Checkpoint Inhibitors Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Combination Therapies; Emerging Checkpoint Inhibitors
7. Checkpoint Inhibitors Market Regional And Country Analysis: 7.1. Global Checkpoint Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Checkpoint Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Checkpoint Inhibitors Market: 8.1. Asia-Pacific Checkpoint Inhibitors Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Checkpoint Inhibitors Market: 9.1. China Checkpoint Inhibitors Market Overview; 9.2. China Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Checkpoint Inhibitors Market: 10.1. India Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Checkpoint Inhibitors Market: 11.1. Japan Checkpoint Inhibitors Market Overview; 11.2. Japan Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Checkpoint Inhibitors Market: 12.1. Australia Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Checkpoint Inhibitors Market: 13.1. Indonesia Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Checkpoint Inhibitors Market: 14.1. South Korea Checkpoint Inhibitors Market Overview; 14.2. South Korea Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Checkpoint Inhibitors Market: 15.1. Western Europe Checkpoint Inhibitors Market Overview; 15.2. Western Europe Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Checkpoint Inhibitors Market: 16.1. UK Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Checkpoint Inhibitors Market: 17.1. Germany Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Checkpoint Inhibitors Market: 18.1. France Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Checkpoint Inhibitors Market: 19.1. Italy Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Checkpoint Inhibitors Market: 20.1. Spain Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Checkpoint Inhibitors Market: 21.1. Eastern Europe Checkpoint Inhibitors Market Overview; 21.2. Eastern Europe Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Checkpoint Inhibitors Market: 22.1. Russia Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Checkpoint Inhibitors Market: 23.1. North America Checkpoint Inhibitors Market Overview; 23.2. North America Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Checkpoint Inhibitors Market: 24.1. USA Checkpoint Inhibitors Market Overview; 24.2. USA Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Checkpoint Inhibitors Market: 25.1. Canada Checkpoint Inhibitors Market Overview; 25.2. Canada Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Checkpoint Inhibitors Market: 26.1. South America Checkpoint Inhibitors Market Overview; 26.2. South America Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Checkpoint Inhibitors Market: 27.1. Brazil Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Checkpoint Inhibitors Market: 28.1. Middle East Checkpoint Inhibitors Market Overview; 28.2. Middle East Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Checkpoint Inhibitors Market: 29.1. Africa Checkpoint Inhibitors Market Overview; 29.2. Africa Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Checkpoint Inhibitors Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Checkpoint Inhibitors Market Competitive Landscape And Company Profiles: 30.1. Checkpoint Inhibitors Market Competitive Landscape; 30.2. Checkpoint Inhibitors Market Company Profiles; 30.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Checkpoint Inhibitors Market Other Major And Innovative Companies: 31.1. Incyte Corporation; 31.2. Novartis AG; 31.3. NewLink Genetics Corporation; 31.4. Seattle Genetics Inc.; 31.5. Celldex Therapeutics; 31.6. GlaxoSmithKline plc; 31.7. Innate Pharma S.A.; 31.8. Ono Pharmaceutical Co. Ltd.; 31.9. Juno Therapeutics; 31.10. Kite Pharma; 31.11. Eli Lilly and Company (ARMO Biosciences); 31.12. Fortress Biotech; 31.13. Argenx SE; 31.14. MacroGenics; 31.15. CureTech
32. Global Checkpoint Inhibitors Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Checkpoint Inhibitors Market
34. Recent Developments In The Checkpoint Inhibitors Market
35. Checkpoint Inhibitors Market High Potential Countries, Segments and Strategies: 35.1 Checkpoint Inhibitors Market In 2029 - Countries Offering Most New Opportunities; 35.2 Checkpoint Inhibitors Market In 2029 - Segments Offering Most New Opportunities; 35.3 Checkpoint Inhibitors Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now